Healthcare Professionals: Training and Education | DVT/PE | NCBDDD | CDC

Healthcare Professionals: Training and Education | DVT/PE | NCBDDD | CDC

• Blood clots affect up to 900,000 Americans and lead to about 100,000 deaths every year―but they are often preventable.
• Treatment for blood clots can cost as much as $15,000 to $20,000 per person, with estimated health costs of $10 billion annually in the United States.
• Healthcare professionals and health department staff can Stop the Clot, Spread the Word™ [PDF-317KB] about blood clots and even take a free continuing education training.

Healthcare Professionals: Training and Education

Stop the Clot®:
What Every Healthcare Professional Should Know

Course Overview: This self-paced, online course provides the most current foundational information on assessing, treating, and managing patients who have blood clots and clotting disorders.

Target Audience: Physicians, Pharmacists, Nurses, Nurse Practitioners, Physician Assistants, Other Healthcare Professionals

Content:

1. Basics of Blood Clots
2. Thrombophilia and Blood Clots
3. Anticoagulation Medications
4. Post-Thrombotic Syndrome
5. Pulmonary Hypertension
6. Prevention of Blood Clots

Course Objectives

At the conclusion of this curriculum, participants will be able to do the following:

• Explain three signs and symptoms of deep vein thrombosis (DVT) and pulmonary embolism (PE).
• Describe three factors that increase the risk of developing a blood clot in the form of a DVT and/or PE.
• Describe three management considerations for the use of anticoagulant medications.
• Explain three signs and symptoms of post-thrombotic syndrome that providers should include in patient education plans for blood clot survivors.
• Explain two facts about pulmonary hypertension and its relationship to PE.
• Describe three appropriate treatment/management options to prevent clot recurrence and secondary complications.

WEBINAR SERIES:
Bleeding and Clotting Disorders

The purpose of this series is to provide evidence-based information on new research, interventions, emerging issues of interest in blood disorders, as well as innovative approaches in collaborations and partnerships. We invite you to join us in this series.

More

Prerequisite Skills and Knowledge

General knowledge of a discipline of study related to health care

Continuing Education

This course has been approved for the following continuing education credits:

2.5 CME (Continuing Medical Education hours)

2.5 CPE (Contact hours in Pharmacy Education)

0.2 CEU (Continuing Education Units)

2.4 CNE (Continuing Nursing Education)

Accreditation Statements

• CME activities with Joint Providers: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Centers for Disease Control and Prevention and National Blood Clot Alliance. The Centers for Disease Control and Prevention is accredited by the ACCME® to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 2.5 AMA PRA Category 1 Credits™.
• CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 2.4 contact hours.
• CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.2 CEU’s for this program.
• CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 2.5 Contact Hours in pharmacy education.

Faculty

• Mary Lou Damiano, RN, MA, Co-Director, Hemophilia & Thrombosis Center, University of Arizona, Consultant to the National Blood Clot Alliance
• Kathleen McCool, PharmD, BCPS, CACP, Supervisor; Clinical Pharmacy Anticoagulation and Anemia Services, Kaiser Permanente Colorado
• Theresa Ransone, PA-C, MPAS, MT (ASCP)SH Thrombophilia Clinic, Gonda Vascular Center, Mayo Clinic,
• Frederick R. Rickles, MD, FACP, Professor of Medicine, Pediatrics and Pharmacology and Physiology, The George Washington University
• Darren Triller, Pharm D., Senior Project Director for IPRO, the Centers for Medicare and Medicaid Services (CMS)-designated Quality Improvement Organization (QIO) for New York State
• Elizabeth Varga, MS, CGC, Research Coordinator/Certified Genetic Counselor & Clinical Assistant Professor of Pediatrics, Center for Molecular and Human Genetics, The Research Institute at Nationwide Children’s Hospital
• Diane Wirth, MS, ANP-BC, CACP, Adult Nurse Practitioner with Provider Health Services and Consultant to National Blood Clot Alliance

The National Blood Clot Alliance developed and designed this curriculum with support provided by the Centers for Disease Control and Prevention under Cooperative Agreement number 5U27DD000545.

Financial Disclosure Statement

There was no commercial support received for this activity. Presentations do not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial support for this continuing education activity.

Registration

To access this online curriculum, please enable cookies in your browser.

Click hereto register

If you have already registered and are returning to continue your course, please click here.

Please address general questions or comments about the curriculum to info@stoptheclot.org.

If you have questions or comments about the evaluation portion of the curriculum, or the acquisition of continuing education credit, please contact: CDC/ATSDR Training and Continuing Education Online, 1-800-41TRAIN, or email at ce@cdc.gov.